QUALIFIED MEDICAL EXAMINER for California State Certified Worker’s Compensation, 1991.
NEVADA STATE RINGSIDE DOCTOR, Nevada State Athletic Commission, 2008-present.
PROFESSIONAL SOCIETIES:
1974 American Chemical Society
1980 American Medical Association
1981 American Academy of Ophthalmology
1985 American Society of Ophthalmic Plastic and Reconstructive Surgery
1985 American Society of Cataract and Refractive Surgery
1985 Los Angeles County Medical Association
1985 Los Angeles Eye Society
2008 American College of Surgeons
TEACHING AND ACADEMIC POSITIONS:
1985-Present Assistant Clinical Professor of Ophthalmology, Attending Surgeon, Jules Stein Eye Institute, UCLA Medical Center, Los Angeles, California
1985-2003 Director Ophthalmic Plastic, Orbital Surgery and Trauma, Martin Luther King Hospital, UCLA Medical School
1991-1994 Chief of Ophthalmology, Midway Hospital Los Angeles, California
1984-1984 Program Originator and Instructor for Orbital and Ocular Plastic Trauma Service, Massachusetts Eye and Ear Infirmary, Harvard University
1981-1985 Clinical Fellow, Harvard University
1974-1975 Inorganic Chemistry Preceptor, Brandeis University
BOARD CERTIFICATION:
1985 Diplomate, American Board of Ophthalmology
1986 Fellow, American Society of Ophthalmic Plastic Reconstructive Surgery
CHARITABLE ENDEAVORS
1996-2008 Founders Group (Active Member) Sponsored and Organized the annual Las Vegas PGA event, and numerous other charitable golf tournaments.
Dispensed over 15 million dollars to local charities.
Medical Director of PGA Events
BIBLIOGRAPHY:
1. S. Leibowitz, A.S. Grove, N. Kolodny, New Approach to Orbital Diagnosis Using 31 P NMR Spectroscopy, American Academy of Ophthalmology, November 1986.
2. S. Leibowitz, A.S. Grove, N. Kolodny, New Approach of Orbital Diagnosis Using 31 P NMR spectroscopy, American Society of Ophthalmic Plastic and Reconstructive Surgery Thesis, November 1986.
3. S. Leibowitz, A.S. Grove, N. Kolodny, New Approach to Orbital Diagnosis Using 31 P NMR Spectroscopy, ARVO, May 1985.
4. S. Leibowitz, I.R. Epstein, Resonance Structures In Boron Hybrids, Journal of the American Chemical Society, May 1975.
RECENT LECTURES:
1. Cosmetic Laser Resurfacing, UCLA Laser Course, American Academy of Ophthalmology, October 1995.
2. Cosmetic Laser Resurfacing, Luxar Laser Course, Las Vegas, Nevada, May 1996.
3. Cosmetic Laser Resurfacing, UCLA Laser Course, American Academy of Ophthalmology, October 1996.
4. C.L.R., Luxar Laser Course, Las Vegas, Nevada, February 1997
5. Blepharoplasty and Cosmetic Laser Resurfacing Forum, Annual Jules Eye Stein Eye Institute Meeting, April 1997.
6. Cosmetic Laser Resurfacing and Blepharoplasty, Jules Stein Annual Meeting, April 1997.
7. Blepharoplasty and Cosmetic Laser Resurfacing, UCLA Laser Course, American Academy of Ophthalmology, October 1997.
8. Comprehensive Cosmetic Blepharoplasty and Laser Resurfacing, UCLA School of Medicine, American Medical Association, June 1998.
9. New Techniques in Facial and Body Fat Contouring, UCLA School of Medicine, American Medical Association, March 1999.
10. Orbital Surgery: A Master’s Symposium and Dissection Workshop, UCLA School of Medicine, Jules Stein Eye Institute, American Medical Association, December 1999.
11. Annual Jules Stein Eye Institute Postgraduate Seminar, Jules Stein Eye Institute, American Medical Association, June 2001.
12. Aesthetic Eyelid & Orbitofacial Surgery: Options and Finesse, Jules Stein Eye Institute, American Medical Association, June 2001.
13. Annual Meeting, New Orleans, American Academy of Ophthalmology, November 2001.
14. XXIXth International Congress of Ophthalmology, American Academy of Ophthalmology, July 2002.
15. Lasik Audio Conference- Malpractice Litigation Update, American Academy of Ophthalmology, July 2002.
16. Joint Meeting, Orlando, American Academy of Ophthalmology, October 2002.
17. Upper, Mid and Lower Facelift: Dissection and Live Surgery, Jules Stein Eye Institute, American Medical Association, April 2003.
18. Ring Physicians Medical Course, Dr. Voy, Course Director, Olympic Training Center, Colorado, Jan. 2004
19. Graves Disease International Symposium November 17-18, 2007, American Academy of Ophthalmology, Course Instructor
20. American Academy of Ophthalmology, Graves Disease Course Instructor, Nov. 2007, Las Vegas, Nv.
21. International Thyroid Eye Disease Study Group, Meetings in Los Angeles, New York, Ft. Lauderdale, Design and Implementation of International Scientists to Perform Future Clinical Trials in Thyroid Eye Disease. 2007-2008
22. Ophthalmic Plastic, Orbital Anatomy, and Cosmetic Surgery Seminar, Jules Stein Eye Institute, UCLA School of Medicine, Course Instructor, July 2008.
23. Blepharoplasty Course, Jules Stein Eye Institute, Course Instructor, June 2009.
24. European Group on Grave’s Orbitopathy (EUGOGO) Meeting, Amsterdam, Netherlands, Grave’s Disease Clinical Trials Planning.
Graves' disease is an autoimmune disease. It most commonly affects the thyroid, causing it to grow to twice its size or more (goiter), be overactive, with related hyperthyroid symptoms such as increased heartbeat, muscle weakness, disturbed sleep, and irritability. It can also affect the eyes, causing bulging eyes (exophthalmos). It affects other systems of the body, including the skin and reproductive organs. It affects up to 2% of the female population, often appears after childbirth, and has a female:male incidence of 5:1 to 10:1. It has a strong hereditary component; when one identical twin has Graves' disease, the other twin will have it 25% of the time. Smoking and exposure to second-hand smoke is associated with the eye manifestations but not the thyroid manifestations. Diagnosis is usually made on the basis of symptoms, although thyroid hormone tests may be useful, particularly to monitor treatment.
Home
